Patent · US Active

Compositions and methods for treating cardiovascular disease

US11034725B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 26, 2020
Grant dateJun 15, 2021
Priority date
Expiry dateMay 26, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides PCSK9 inhibitors, compositions comprising the PCSK9 inhibitors, and methods of identifying and using the PCSK9 inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.